TY - JOUR
T1 - Novel method to select meaningful outcomes for evaluation in clinical trials
AU - McLeod, Charlie
AU - Norman, Richard
AU - Wood, Jamie
AU - Mulrennan, Siobhain
AU - Morey, Sue
AU - Schultz, André
AU - Messer, Mitch
AU - Spaapen, Kate
AU - Stoneham, Matthew
AU - Wu, Yue
AU - Smyth, Alan
AU - Blyth, Christopher
AU - Webb, Steve
AU - Mascaro, Steven
AU - Woodberry, Owen
AU - Snelling, Tom
N1 - Funding Information:
Funding This work was supported by a Perth Children’s Hospital New Investigator grant (9757). CM is supported by an NHMRC post-graduate scholarship (GNT1150996), and top-up grants from the Wesfarmers Centre (top-up grant) and the Perth Children’s Hospital Foundation (9722). TS is supported by a Career Development Fellowship from the National Health and Medical Research Council (GNT1111657). CB is also supported by the National Health and Medical Research Council (1111596/1173163).
Publisher Copyright:
©
PY - 2021
Y1 - 2021
N2 - Background A standardised framework for selecting outcomes for evaluation in trials has been proposed by the Core Outcome Measures in Effectiveness Trials working group. However, this method does not specify how to ensure that the outcomes that are selected are causally related to the disease and the health intervention being studied. Causal network diagrams may help researchers identify outcomes that are both clinically meaningful and likely to be causally dependent on the intervention, and endpoints that are, in turn, causally dependent on those outcomes. We aimed to (1) develop a generalisable method for selecting outcomes and endpoints in trials and (2) apply this method to select outcomes for evaluation in a trial investigating treatment strategies for pulmonary exacerbations of cystic fibrosis (CF). Methods We conducted a series of online surveys and workshops among people affected by CF. We used a modified Delphi approach to develop a consensus list of important outcomes. A workshop involving domain experts elicited how these outcomes were causally related to the underlying pathophysiological processes. Meaningful outcomes were prioritised based on the extent to which each outcome captured separate rather than common aspects of the underlying pathophysiological process. Results The 10 prioritised outcomes were: breathing difficulty/pain, sputum production/clearance, fatigue, appetite, pain (not related to breathing), motivation/demoralisation, fevers/night sweats, treatment burden, inability to meet personal goals and avoidance of gastrointestinal symptoms. Conclusions This proposed method for selecting meaningful outcomes for evaluation in clinical trials may improve the value of research as a basis for clinical decisions.
AB - Background A standardised framework for selecting outcomes for evaluation in trials has been proposed by the Core Outcome Measures in Effectiveness Trials working group. However, this method does not specify how to ensure that the outcomes that are selected are causally related to the disease and the health intervention being studied. Causal network diagrams may help researchers identify outcomes that are both clinically meaningful and likely to be causally dependent on the intervention, and endpoints that are, in turn, causally dependent on those outcomes. We aimed to (1) develop a generalisable method for selecting outcomes and endpoints in trials and (2) apply this method to select outcomes for evaluation in a trial investigating treatment strategies for pulmonary exacerbations of cystic fibrosis (CF). Methods We conducted a series of online surveys and workshops among people affected by CF. We used a modified Delphi approach to develop a consensus list of important outcomes. A workshop involving domain experts elicited how these outcomes were causally related to the underlying pathophysiological processes. Meaningful outcomes were prioritised based on the extent to which each outcome captured separate rather than common aspects of the underlying pathophysiological process. Results The 10 prioritised outcomes were: breathing difficulty/pain, sputum production/clearance, fatigue, appetite, pain (not related to breathing), motivation/demoralisation, fevers/night sweats, treatment burden, inability to meet personal goals and avoidance of gastrointestinal symptoms. Conclusions This proposed method for selecting meaningful outcomes for evaluation in clinical trials may improve the value of research as a basis for clinical decisions.
KW - cystic fibrosis
KW - paediatric lung disaese
KW - rare lung diseases
KW - respiratory infection
UR - http://www.scopus.com/inward/record.url?scp=85117109115&partnerID=8YFLogxK
U2 - 10.1136/bmjresp-2021-000877
DO - 10.1136/bmjresp-2021-000877
M3 - Article
C2 - 34620699
AN - SCOPUS:85117109115
SN - 2052-4439
VL - 8
JO - BMJ Open Respiratory Research
JF - BMJ Open Respiratory Research
IS - 1
M1 - e000877
ER -